
Inhibitors of Molecular Chaperones as Therapeutic Agents
- 352 pages
- English
- PDF
- Available on iOS & Android
Inhibitors of Molecular Chaperones as Therapeutic Agents
About this book
This book aims to provide a comprehensive examination of the field of molecular chaperone inhibition and its application to pharmaceutical research. With several small molecule inhibitors in oncology clinical development, there is clearly intense interest in the chaperones as a molecular target. Filling a significant gap in the market by providing a detailed comparison of discovery programs across the industry, this text will find broad interest among researchers in the field of molecular chaperone pharmaceutical research, oncology research, and medicinal chemistry.
Arranged into three main sections the book covers structure and function, small molecule inhibitors and concludes with a section discussing clinical perspectives. With specific chapters covering the discovery of key molecules such as, BIIB028, STA-9090, Serenex Hsp90 inhibitor, NVP-AUY922 and NVP-HSP990, this comprehensive text is an essential treatise for researchers working in academia and industry.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Inhibitors of Molecular Chaperones as Therapeutic Agents
- Contents
- Chapter 1 Overview of Molecular Chaperones in Health and Disease
- Chapter 2 Structural Basis of Hsp90 Function
- Chapter 3 Structure and Function of Hsp70 Molecular Chaperones
- Chapter 4 Exploiting the Dependency of Cancer Cells on Molecular Chaperones
- Chapter 5 The Discovery of BIIB021 and BIIB028
- Chapter 6 Discovery and Development of Ganetespib
- Chapter 7 Discovery of the Serenex Hsp90 Inhibitor, SNX5422
- Chapter 8 Discovery of NVP-AUY922
- Chapter 9 Discovery and Selection of NVP-HSP990 as a Clinical Candidate
- Chapter 10 Inhibitors of the Hsp90 C-terminus
- Chapter 11 Hsp70 Inhibitors
- Chapter 12 The Cancer Super-chaperone Hsp90: Drug Targeting and Post-translational Regulation
- Chapter 13 Hsp90 Inhibitors in Clinic
- Chapter 14 Heat-shock Protein 90 as an Antimalarial Target
- Chapter 15 Molecular Chaperones as Potential Therapeutic Targets for Neurological Disorders
- Subject Index